Jpmorgan Chase & CO Rockwell Medical, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.65MCall Options Held
45.7KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY3.58MShares$9.42 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$3.17 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$1.95 Million0.29% of portfolio
-
Perkins Capital Management Inc350KShares$921,4881.37% of portfolio
-
Geode Capital Management, LLC Boston, MA307KShares$808,1830.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $28.1M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...